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Background: In Nigeria and elsewhere, informal drug sellers, or patent and proprietary medicine vendors (PPMVs),
are a common source of care for children with malaria, diarrhoea, and pneumonia. However, their knowledge and
stocking of recommended treatments for these common childhood illnesses are not well understood.
Methods: A census of PPMV shops was conducted in Kogi and Kwara states. A shop survey was conducted on a
subset of 250 shops. Multivariate regression analysis was used to assess associations between shop worker
characteristics and (1) knowledge of optimal treatments for malaria, diarrhoea, and pneumonia, and (2) stocking of
essential medicines to treat these illnesses.
Results: From the census, 89.9 % of shops stocked oral rehydration solution (ORS), while 61.1 % of shops stocked
artemisinin-based combination therapies and 72.2 % of shops stocked amoxicillin. Stocking patterns varied by state,
urban/rural location, and according to whether or not the shop was headed by someone with formal health training
(e.g. having a professional health education degree). In multivariate analyses, selling drugs wholesale and participating
in any training in the past year was associated with a higher likelihood of naming the correct treatment for malaria,
and having formal health training was associated with stocking ORS. However, few other PPMV characteristics were
predictive of correct knowledge of optimal treatments and stocking behaviour.
Conclusion: Many PPMVs lack the knowledge and tools to properly treat common childhood illnesses. PPMV knowledge
and selling of essential medicines for these illnesses should be strengthened to improve child health in Nigeria.
Keywords: Malaria, Pneumonia, Diarrhoea, Nigeria, Private sector, Drug vendors, Integrated management of childhood
illnesses, Community case managementBackground
Pneumonia, diarrhoea, and malaria are the leading
causes of child mortality in Nigeria, from which over
one million children under five are estimated to die each
year [1]. These conditions contribute 16.4, 18.7, and 20.1 %
of the total burden of disease, respectively [1]; thus,
ensuring prompt and proper diagnosis and treatment
for these illnesses is essential for reducing childhood
morbidity and mortality [2].
Treatment guidelines in Nigeria and elsewhere recom-
mend that children exhibiting signs of pneumonia,
including coughing, fever, and rapid breathing, be seen
by a health professional, and if properly diagnosed,
prescribed amoxicillin in dispersible tablet form [3].* Correspondence: cisiguzo@sfhnigeria.org
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creativecommons.org/publicdomain/zero/1.0/Children diagnosed with uncomplicated malaria should be
treated with artemisinin-based combination therapy (ACT)
after, ideally, parasitological confirmation [4, 5]. Children
with diarrhoea should be given low-osmolarity oral
rehydration solution (ORS) in combination with zinc
tablets to reduce the duration and severity of fluid loss [6].
The Integrated Community Case Management (iCCM)
strategy for childhood illnesses adopted by the Nigeria
Ministry of Health (MOH) in 2014 aims to improve access
to these treatments and provide referrals to formal care
when necessary through community-based health workers
or other resource persons [7]. The MOH, in the early
stages of implementing its iCCM strategy, defines iCCM
resource persons as respected community members, aged
18 to 65, and literate, and who are accessible and willing
to participate [7]. Providers eligible to deliver iCCM
include for-profit drug retailers, or patent and proprietarys article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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of care for common health concerns and commodities
[8, 9], including treatment for children under five with
fever or cough [10]. With an estimated over 200,000 shops
in Nigeria [11], PPMVs are highly accessible and are a
particularly important access point for basic health services
among rural and poor households [8, 12, 13].
However, PPMV licensure does not require formal
pharmacy training or a minimum level of education
[14–16], which raises concerns about the quality of care
that PPMVs provide. PPMV licensure is currently under
review by the Pharmacy Council of Nigeria (PCN), and
some PPMVs have formal medical training, such as
nursing or pharmacy. PPMVs are permitted to sell pre-
packaged, over-the-counter drugs (e.g. ACT, ORS) but
not prescription drugs (e.g. antibiotics) [17]. Past studies
of PPMVs in Nigeria have found they may improperly
identify and treat common childhood illnesses [18, 19],
and that many PPMVs sell drugs and services beyond
their legal scope of practice [11, 16]. Because PPMVs
are for-profit microenterprises, they are particularly
responsive to what their customers ask of them [14, 20],
which may lead to under-stocking and under-provision of
low-demand products, such as zinc [21]. Despite their
central role in delivering treatments for childhood
illnesses [10]. Little is known about how PPMVs provide
integrated disease management for children [22]. The few
existing studies of PPMV practices around childhood
illness focus almost exclusively on malaria [16, 23, 24],
with only one study on childhood diarrhoea [25] and none
on pneumonia [22].
Because of their abundance, accessibility, and eligibility
as an iCCM provider, coupled with concerns over quality
of care, this study of PPMV practices examines their
stocking practices and knowledge for three common
childhood illnesses, malaria, diarrhoea, and pneumonia,
for which there is scant existing evidence. Specifically,
this paper aims to describe PPMVs’ stocking patterns of
essential medicines to treat malaria, pneumonia, and
diarrhoea, and assess associations between shop worker
characteristics and knowledge and stocking of optimal
treatments for these diseases. Understanding PPMVs’
knowledge and stocking of malaria, pneumonia, and
diarrhoea treatments in the context of iCCM scale-up in
Nigeria is important as they are a primary point of care




A census of all retail establishments selling drugs in
Kogi and Kwara states was conducted from April to
September 2013. Kogi and Kwara states were chosen to
represent Nigeria’s central region, with mixed populationsby religion, socio-economic status, ethnicity, and mix of
urban, peri-urban, and rural areas, in comparison to
southern Nigeria, where a majority of studies in Nigeria
are concentrated [24].
This census listing produced a database of 2,083 shops
(1,088 in Kogi, 995 in Kwara), and collected limited
information on shop owner and worker characteristics,
and the types, doses, and brands of medicines stocked
for malaria, pneumonia, and diarrhoea. From this listing,
250 shops (125 in each state) were selected for a survey that
collected additional information on shop characteristics,
services, and knowledge and practices of shop workers. The
sub-sample included in the survey was not meant to be
representative of the census, but to generate an analytical
sample. Due to logistical challenges and security concerns
of extended periods of stay in certain areas, the sub-sample
was chosen through a modified stratified random sampling
approach. In each state, shops within a 25-km radius of the
center of four urban or peri-urban hubs (ranging
from 21 to 39 shops per hub) were randomly selected,
stratified across urban, peri-urban, and rural loca-
tions (Kogi: Ayangba, Ida, Lokoja, and Okene; Kwara:
Ajase-Ipo, Bode-Sadu, Ilorin, and Omu-Aran). In con-
sultation with a geospatial expert, a 25-km was deter-
mined to be sufficient to generate a difference in urban,
peri-urban, and rural locations. If a shop could not be
located (due to absent provider, closed shop, or incorrect
address), the next closest shop was selected as a substitute
(Kogi: 30 shops, Kwara: 24 shops) to preserve sample
stratification, regardless of its inclusion on the census, and
to account for shops that opened after the census was
taken. All shops selected in the sampling process or
identified as a substitute were eligible to participate.
Data collection
From Monday to Saturday in September and October
2013, one multi-lingual study surveyor was assigned to
visit one shop per day. Upon arrival, the surveyor
self-identified as working with a non-profit organization
focused on health, and sought consent from the person in
charge (79.2 % shop owner, 6.8 % manager, 13.2 % appren-
tice, 0.8 % other). Shop owners were not given advance
notice. All shops located and approached for consent
agreed to participate.
Surveyors administered the survey in the morning
when customer traffic was typically low. Interruptions
for attending to customers were permitted. The survey
instrument was designed to collect information on shop
owners’ and workers’ sociodemographic characteristics,
self-reported knowledge and practices for treating child-
hood malaria, diarrhoea, and pneumonia, resources for
drug and healthcare advice, and training. Participants
were given a small gift for participation (wall clock
valued at 500 Naira [~US$3.13]).
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Two outcome measures were analyzed in this paper: (1)
correct knowledge of the most effective drug to treat
malaria and diarrhoea; and (2) whether the shop stocked
at least one effective drug for the treatment of malaria
and diarrhoea. Due to the extremely low recognition
and understanding of pneunomia among respondents,
multivariate analyses of outcomes for pneumonia were
not possible (see results). Further, diagnosis is excluded as
an outcome because PPMVs are not legally allowed to per-
form diagnostic tests. Knowledge of the most effective
drug to treat childhood malaria, diarrhoea, or pneumonia
was coded as correct if the respondent answered with
ACT, ORS, or amoxicillin, respectively. While other
appropriate treatments exist for these illnesses, ACT,
ORS, and amoxicillin were chosen because they are
listed as optimal treatments under iCCM guidelines.
Stocking of zinc for treatment of diarrhea is excluded
as an outcome due to its extremely low prevalence in
the study area. Respondents were asked about treatments
for specific diseases and symptoms; where they provided
brand names, responses were recoded to the type of
medicine, such as “ACT” for “Coartem.”
Data analysis
In bivariate analysis, differences in knowledge of most
effective treatments, drug stocking, shop characteristics
[state, location (urban, peri-urban, or rural), registration
with the PCN, selling wholesale drugs, and offering tests
or examinations to customers], and respondents’ char-
acteristics (age, sex, education, years of experience
working at a drug shop, religion, proportion of house-
hold income from the shop, and participation in any
type of training in the past year) between respondents
with and without formal health training are examined.
Respondents self-reporting health training as a doctor,
nurse, midwife, pharmacist, laboratory technician, or
community health extension worker (CHEW) were con-
sidered to have formal health training, while current or
finished PPMV apprentices were considered not to have
formal health training. In addition to retail sales, some
PPMVs sell drugs wholesale to other PPMVs or pharma-
cies. Respondents self-reported whether they provide
examinations or diagnostic tests, such as malaria rapid
diagnostic tests or physical examinations. Respondents
who reported that more than half of their household
income was generated from the PPMV shop were coded
as having the majority of their household income come
from the shop.
For treatment knowledge and stocking outcomes, multi-
variate analyses were conducted using logistic regressions.
It is important to note that too few respondents gave cor-
rect answers for pneumonia treatment, which precluded
further multivariate analysis (see results). Covariates forPPMV shop and worker characteristics were selected based
on a priori hypotheses of determinants of knowledge and
stocking practices and included those listed above.
Analyses were conducted using STATA SE Version 13.1.
Interaction effects were tested to explore whether PPMVs
with formal health training had significantly different
knowledge or stocking practices if they were male,
had more years of experience, or were located in an
urban area. As none were significant, they are not included
in the final analysis. Alternative categorizations of age,
years of experience, and profession were examined to
assess sensitivity, but resulting estimates did not
change substantive findings. It is important to note that the
Affordable Medicines Facility-malaria (AMFm) programme,
an international subsidy on ACTs to increase its supply
and affordability and reduce the use of non-recommended
anti-malarials, which included a malaria and malaria
training programme for participating providers, operated in
the study area [20]. Selected retail outlets, including some
larger PPMVs, participated in the AMFm programme as
distributors, and many PPMVs were recipients of the subsi-
dized retail products and training component. We explored
the independent effect of AMFm inclusion, but, because
participation in the AMFm program was not associated
with our outcome measures, it is not included in the final
analysis.Ethical considerations
Ethical approval was obtained from the National Health
Research Ethics Committee of Nigeria (NHREC/01/01/
2007-05/09/2013). Surveyors obtained written informed
consent from all persons in charge at selected shops.Results
Stocking patterns from the PPMV shop census
A total of 1,088 PPMV shops in Kogi and 995 in Kwara
were identified during the census. 33.3 % of Kogi shops
and 12.2 % of Kwara shops participated in the AMFm
programme. Figure 1 displays the stocking patterns for
essential medicines across urban, peri-urban, and rural
locations. In Kogi, stocking of any form of amoxicillin
was higher in urban areas (89.3 %) compared to peri-urban
(80.9 %) and rural (63.5 %) areas. In Kwara, the trend for
amoxicillin stocking was reversed: 59.7 % among urban
PPMVs, increasing to 69.5 % of peri-urban shops and
80.4 % of rural shops. Although lower in Kwara, stocking
of ACTs in Kogi and Kwara was highest in urban areas
(80.3 and 61.9 %, respectively) compared to peri-urban
(71.5 and 48.5 %, respectively) and rural (62.8 and 42.1 %,
respectively) shops. Of the essential medicines, availability
of ORS was highest overall, with 85.0 % (urban Kwara) to
93.5 % (rural Kogi) of PPMV shops stocking it. Less than
3 % of all PPMVs stocked zinc tablets. Zinc stocking was
Fig. 1 Stocking of essential medicines by location at Kogi and Kwara PPMVs. The percentage of PPMVs (n = 2083) stocking different essential
medicines for the treatment of childhood illnesses was plotted according to state and location type within state. Within each drug or commodity
type, all brands and dosages are grouped together (Source: Census). 1ACTs = artemisinin-based combination therapy 2ORS = oral rehydration solution
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stocked zinc in urban Kwara.
Overall, 57.0 % of PPMVs had some type of formal
health training, of whom 30.4 % were nurses or midwives,
21.5 % CHEWs, 4.3 % pharmacists, and 0.7 % doctors.Fig. 2 Stocking of essential medicines by formal medical training at Kogi a
different essential medicines for the treatment of childhood illnesses was p
health training. Within each drug or commodity type, all brands and dosag
combination therapy 2ORS = oral rehydration solution 3CHEW = communitAmong shop owners and workers with formal health
training, over three-quarters (86.7 % of doctors, 75.9 % of
nurses/midwives, 84.3 % of CHEWs, and 79.3 % of
pharmacists) stocked amoxicillin, while only 68.2 % of
PPMVs without formal health training did so (Fig. 2). And Kwara PPMVs. The percentage of PPMVs (n = 2015) stocking
lotted according to the shop owner’s self-reported type of formal
es are grouped together (Source: Census). 1ACTs = artemisinin-based
y health extension worker
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or doctors stocked ACT (80.4 % and 80.0 %, respectively),
compared to PPMVs who were CHEWs (61.3 %), nurses/
midwives (61.3 %), and those without formal health training
(63.3 %). Stocking of ORS was very high overall, with
100 % of doctors and over 90 % of all other shop
owner types stocking it. Stocking of zinc was highest
among nurses/midwives (12.7 %) and pharmacists (8.5 %),
but was less than 3 % of CHEWs and those without
formal health training, and no doctors stocked zinc.
Shop survey sample characteristics
For the subset of PPMVs shops selected for the shop
survey, basic characteristics of the shop and the person
in charge are summarized in Table 1. Overall, 21.2 % of
PPMVs in the shop survey had any formal health
training. The percentage of PPMVs with formal health
training differs between the census and the shop survey
due to two reasons: (1) The random sampling frame
employed in the shop survey had to be modified to
accommodate logistical challenges and security risks;
(2) Some shops enumerated from the census were not
able to be located if they were no longer in business,
and replacement shops may include new businesses
that were newly operational since the census was taken.
Limitations are discussed in the following section.
A majority of formally trained PPMVs were CHEWs
(52.8 %), followed by nurses/midwives (34.0 %), laboratory
technicians (7.6 %), and pharmacists (5.7 %). Among
PPMVs without health training, 67.7 % had completed an
apprenticeship; 32.3 % were current PPMV apprentices or
did not report any form of formal or informal training. In
this sample, a higher percentage of PPMVs in Kwara
had health training (60.4 % versus 39.6 % in Kogi),
while PPMVs without formal health training were evenly
distributed between the two states. A slightly higher
proportion of health-trained PPMVs were in a rural area
(47.2 % versus 20.8 % and 32.1 % in urban and peri-urban
areas, respectively). Those without formal training were
more evenly distributed across locations.
Over half of health-trained and untrained PPMVs were
male (52.8 and 60.3 %, respectively). The mean (SD) age
of health-trained respondents was nine years older than
untrained respondents—40.0 years (12.3) compared to
31.0 years (10.9), respectively (p = 0.000). A higher
percentage of PPMVs were Christian than Muslim.
Both educational attainment and experience working at a
PPMV shop were significantly higher among respondents
with health training than those without: 94.3 % versus
23.4 % with post-secondary education (p = 0.000), respect-
ively; a mean (SD) of 16.7 years (11.2) of PPMV work
experience versus 10.5 years (8.2; p = 0.000), respectively.
Health-trained PPMVs were significantly more likely to
offer tests or examinations to customers (52.8 %) thanuntrained PPMVs (30.3 %; p = 0.002). Differences between
health-trained and untrained PPMV were not observed
for respondents who reported that more than half of their
household income came from the shop, that their shop
sold drugs wholesale, or that the shop was registered with
the PCN.
Differences between respondents with and without
formal health training were not statistically significant
for naming of the most effective treatments for malaria,
diarrhoea, or pneumonia, or stocking of ACT, ORS, or
amoxicillin.
Multivariate analyses of the correlates of knowledge and
stocking of most effective treatments
In multivariate analysis (Table 2), characteristics associated
with having higher odds of correctly naming the most
effective treatment for malaria included residing in Kogi
state (OR = 4.093; 95 % CI 1.711–9.793), being a PCN
member (OR = 3.181;95 % CI 1.165–8.685), selling drugs
wholesale (OR = 4.230; 95 % CI 1.351– 13.680), and
having participated in any trainings in the previous
year (OR = 2.397; 95 % CI 1.135 - 5.060). No PPMV
characteristics were significantly associated with stocking
ACTs. State was the only characteristic associated with
naming the most effective treatment for diarrhoea
(Table 3): respondents in Kogi were significantly less likely
to identify ORS than those in Kwara (OR = 0.240;
95 % CI 0.104 - 0.555). Respondents with formal
health training were significantly more likely to stock
ORS than those without health training (OR = 2.625;
95 % CI 1.103 - 6.802). No other covariates significantly
predicted stocking of ORS. Paediatric formulations of
amoxicillin are not available in Nigeria; therefore, any
reported amoxicillin stocking, which is against current
PPMV regulations, is for adult formulations. For this
reason, further analysis of this outcomes was excluded.
Discussion
Drug retailers, such as PPMVs, provide a majority of drugs
to treat childhood illnesses in low- and middle-income
countries and have the potential to contribute to advancing
child health. However, this and other studies [12, 19, 26]
have indicated that PPMVs do not always properly treat
common childhood illnesses. In Kogi and Kwara states,
about 75 % of shops stocked ORS and ACT, the majority of
shops offered amoxicillin contrary to current regulations,
and those stocking zinc were minimal.
The results also indicate that although many PPMVs
stock treatments for pneumonia, diarrhoea, and malaria,
knowledge of the most effective treatment is lower.
Moreover, having formal health training was not signifi-
cantly associated with naming the most effective treatments
for malaria or diarrhoea in multivariate analyses, and was
only statistically related to stocking of ORS. Hence, even
Table 1 PPMV Shop characteristics (Source: Shop survey)a
Health training n (%) No health training (%) p-value
Knowledge of shop workers and owners
Named most effective treatment for malaria 39 (73.6) 135 (68.5)
Named most effective treatment for diarrhoea 15 (32.0) 63 (28.3)
Named most effective treatment for pneumonia 0 (0.0 %) 1 (0.5 %)
Drug stockingb
Stocked ACTc for malaria treatment 38 (71.7) 144 (73.9)
Stocked ORSd for diarrhoea treatment 45 (84.9) 146 (74.9)
State
Kogi 21 (39.6) 103 (52.3)
Kwara 32 (60.4) 94 (47.7)
Location
Urban 11 (20.8) 59 (30.0)
Peri-urban 17 (32.1) 68 (34.5)
Rural 25 (47.2) 70 (35.5)
Male respondentse 28 (52.8) 117 (60.3)
Age of respondentb mean ± SD (years) 40.0 ± 1.7 31.0 ± 7.5 0.000
Religiona
Christian 36 (67.9) 115 (59.0)
Muslim 17 (32.1) 80 (41.0)
Education 0.000
Primary 1 (1.9) 12 (6.1)
Secondary 2 (3.8) 139 (70.6)
Post-secondary 50 (94.3) 46 (23.4)
Profession/Formal health trainingb
Current PPMV apprentice or no training - 57 (32.3)
Finished PPMV apprentice - 132 (67.7)
CHEWf 28 (52.8) -
Laboratory technician 4 (7.6) -
Pharmacist 3 (5.7) -
Nurse or midwife 18 (34.0) -
Mean years of experience working at a PPMV shopb 16.7 ± 1.6 10.5 ± 0.6 0.000
Proportion of household income from PPMV shop
Half or less 30 (56.6) 89 (45.2)
More than half 23 (43.4) 108 (54.8)
Shop sells wholesale drugsg 8 (15.1) 37 (18.9)
Member of PCN 11 (20.8) 35 (17.8)
Shop offers tests or examinations to customers 28 (52.8 %) 59 (30.3 %) 0.002
Participated in any trainings in past 12 months 36 (69.2 %) 124 (66.3 %)
Number of observations 53 197





fcommunity health extension worker
gn = 249
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Table 2 Multivariable logistic regression of the likelihood of the PPMV’s knowledge and stocking of most effective treatments for
malaria. (Source: Shop survey)
Named most effective malaria treatment (n =229) Stocked ACT (n =229)
Odds Ratio (95 % CI) p-value Odds Ratio (95 % CI) p-value
Kogi (vs Kwara) 4.093*** (1.711–9.793) 0.002 0.702 (0.309 - 1.597) 0.399
Urban location (vs rural) 1.794 (0.782–4.093) 0.165 0.713 (0.331 - 1.537) 0.388
Peri-urban location (vs rural) 1.073 (0.486 - 2.370) 0.862 1.346 (0.610 - 2.968) 0.462
Age (years) 0.975 (0.933 - 1.020) 0.273 0.969 (0.930 - 1.012) 0.152
Has formal health training (vs none) 1.658 (0.694 - 3.959) 0.255 0.650 (0.286 – 1.477) 0.304
Years of experience 1.038 (0.979 - 1.101) 0.207 1.048 (0.991 - 1.108) 0.104
Muslim respondent (vs Christian) 0.564 (0.283–1.122) 0.103 0.670 (0.332 - 1.354) 0.265
PCN member (vs not a member) 3.181** (1.165–8.685) 0.024 1.190 (0.524 - 2.703) 0.677
Majority of household income is from shop (vs no) 1.047 (0.521 - 2.103) 0.897 0.540 (0.264 - 1.105) 0.149
Shop sells wholesale drugs (vs no) 4.230** (1.351– 13.680) 0.014 0.643 (0.282 - 1.466) 0.293
Participated in any trainings in previous year (vs no) 2.397** (1.135 - 5.060) 0.022 1.444 (0.723 - 2.873) 0.295
Shop offers tests or examinations to customers (vs no) 0.763 (0.383 - 1.520) 0.442 1.578 (0.796 – 3.128) 0.192
* p < 0.1, ** p < 0.05, *** p < 0.01
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not consistently relate to increased knowledge of optimal
treatment or stocking behaviour. For PPMVs to be engaged
in delivering iCCM, further training is needed to increase
basic health knowledge and improve stocking and selling
practices. Further research should be undertaken to identify
optimal training methods to increase PPMV knowledge.
These findings corroborate other reports that PPMVs
sell a range of medicines beyond their scope of service,
including antibiotics [11, 27, 28], yet under-stock
low-demand products [23]. Concerted campaigns to
increase awareness of prompt treatment for malaria
in combination with supply-side drug subsidies haveTable 3 Multivariable logistic regression of the likelihood of the PPM
diarrhoea. (Source: Shop survey)
Named most effec
Odds ratio (95 % C
Kogi (vs Kwara) 0.240*** (0.104 - 0
Urban location (vs rural) 0.844 (0.376 - 1.89
Peri-urban location (vs rural) 1.272 (0.598 - 2.70
Male (vs female) 0.563 (0.258 - 1.22
Age (years) 1.004 (0.961 - 1.04
Has formal health training (vs no) 0.551 (0.237 - 1.27
Years of experience 0.996 (0.942 - 1.05
Muslim respondent (vs Christian) 0.836 (0.420 - 1.66
PCN member (vs no) 1.690 (0.774 - 3.69
Majority of household income is from shop (vs no) 1.143 (0.573 - 2.27
Shop sells wholesale drugs (vs no) 0.565 (0.227 - 1.40
Participated in any trainings in previous year (vs no) 1.538 (0.746 - 3.25
Shop offers tests or examinations to customers (vs no) 1.119 (0.576 – 2.17
* p < 0.1, ** p < 0.05, *** p < 0.01bolstered the sales of ACTs and resulted in a higher
proportion of shops stocking ACTs across Nigeria [20, 29].
Broader customer demand and awareness of the correct
treatments for other paediatric illnesses are needed to
reinforce optimal PPMV stocking and selling behaviours.
For example, caregiver knowledge of symptoms and
treatment for diarrhoea remains low [23, 30], and a similar
campaign to generate demand for proper care-seeking and
treatment from qualified and trained providers is needed
in concert with increased zinc supply at PPMVs.
Current efforts to implement iCCM in Nigeria must
consider these factors in advance of programme scale-up.
In particular, according to the current implementationV’s knowledge and stocking of most effective treatments for
tive diarrhoea treatment (n =229) Stocked ORS (n =229)
I) p-value Odds ratio (95 % CI) p-value
.555) 0.001 1.524 (0.655 - 3.544) 0.328
3) 0.681 1.237 (0.549 - 2.791) 0.608
5) 0.532 1.093 (0.493 - 2.424) 0.827
8) 0.149 0.783 (0.346 - 1.771) 0.556
9) 0.862 0.966 (0.925 - 1.009) 0.118
9) 0.165 2.625** (1.013 - 6.802) 0.047
3) 0.888 1.017 (0.960 - 1.078) 0.565
4) 0.609 0.613 (0.305 - 1.229) 0.168
2) 0.188 1.849 (0.731 - 4.682) 0.194
9) 0.704 1.322 (0.655 - 2.670) 0.436
9) 0.221 1.923 (0.706 - 5.233) 0.201
0) 0.249 1.253 (0.608 - 2.582) 0.540
1) 0.739 1.076 (0.537 - 2.157) 0.836
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based resource persons trained and certified to deliver
iCCM. Elsewhere, trained community health workers have
successfully participated in iCCM efforts. In Ghana and
Uganda, lay community health workers trained in dosing
and referral for treatment of fever and pneumonia,
respectively, provided appropriate treatment for a majority
of cases among children under five years of age [31, 32].
In Uganda, drug retailers trained in iCCM and given diag-
nostic supplies and pre-packaged child formulations of
ACT, amoxicillin, and ORS and zinc correctly managed
childhood illnesses in 87.7 % of cases [33]. This suggests
that PPMVs may serve as an effective lay cadre of iCCM
providers in Nigeria, if properly trained. However, current
PPMV regulations are inconsistent with iCCM guidelines,
which allow certified providers to treat uncomplicated
diarrhoea, malaria, and pneumonia with ORS and zinc,
ACT, and amoxicillin, respectively. The prohibition of
antibiotic sales at PPMVs precludes legally training them
on the proper treatment of pneumonia or other bacterial
infections, as well as enforcing regulatory mechanisms
to ensure medicines are of high quality and properly
formulated for children. While the large existing numbers
of PPMVs in Nigeria could be leveraged to quickly
increase access to these basic paediatric services, regula-
tions must be harmonized with national policies and
iCCM guidelines to provide PPMVs with the training
necessary to effectively treat uncomplicated episodes of
the most common paediatric illnesses, and recognize and
refer when necessary.
Several limitations of this study should be noted. The
sample of PPMVs was limited by security and logistical
concerns and was not representative of the census,
which may reduce the external generalizability of the
paper’s results. While the census indicated over half of
PPMVs had formal health training, only 20 % in the
shop survey sample reported this. However, the trends
in formal health training are consistent with the census
in terms of state and location type as part of the
sampling stratification. Training and other sociodemo-
grahic characteristics are self-reported. Questionnaires
were written in English and administered in several local
languages, allowing for potential errors in translation.
Stocking practices of essential medicines did not record
which formulations were sold or whether the formulation
stocked was an approved form. Despite these challenges,
this paper provides the most comprehensive assessment
of knowledge and stocking for the integrated treatment of
childhood malaria, diarrhoea, and pneumonia at PPMVs
in Nigeria to date.
Conclusions
PPMVs may provide an opportunity to improve children’s
health at the community level, but several challengesremain, including sub-optimal stocking and selling
practices. Although PPMVs are included as implementers
of iCCM under current guidelines, their role as commu-
nity resource persons remains unclear. There is a need to
ensure PPMVs understand how to correctly administer
the essential medicines they stock through improved
training mechanisms, in order to effectively increase
access to quality-assured paediatric care in Nigeria.
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